Osoyoos Cannabis Inc. (CSE:OSO) (“the Company” or “Osoyoos Cannabis”) commences trading on the Canadian Stock Exchange (“CSE”) on February 21, 2019, under the symbol “OSO”.

There have been a number of significant developments within the Company leading up to our public debut that we wish to highlight to our valued investors.


Osoyoos Cannabis is advancing on a pathway to become a world-leading cannabinoid extraction company. Consequently, the Company has amended its original application for a Cultivation License under the ACMPR, to a Standard Processor License under the Cannabis Act. This application has been submitted through the Indigenous Navigator Program, which is expected to expedite the licensing process. Our application is currently in the review stage.

In furthering this strategy, Osoyoos Cannabis has secured a lease, with the option to purchase, a 10,410 ft2 facility on the Osoyoos Indian Band’s lands in the Senkulmen Business Park in Oliver, BC. The building and its location are perfectly suited for the purposes of cannabinoid extraction. The facility is a former storage warehouse that is in excellent condition and has the ideal dimensions to allow for a phased retrofit. Phase One of this retrofit is approximately 3,500 ft2. The initial architectural designs have been completed and the Company is advancing the build out.

To implement the operating model, Osoyoos Cannabis has purchased and taken possession of four Vitalis Supercritical CO2Extraction Systems, which will operate within the footprint of the Phase One retrofit. These Systems will allow for the processing of up to 50,000 kilograms of dried flower annually, which is expected to produce approximately 4,900 kilograms of winterized output per year.

The ongoing execution of our plan will allow Osoyoos Cannabis to pursue four core business lines:

1) Contract processing for third-party licensed producers, by performing tolling services for the extraction of pharmaceutical-grade, purified oil from cannabis or hemp;

2) Extraction and production of oils to be sold through wholesale contracts to third-party licensed producers;

3) Leverage our extraction expertise for the development of cannabis concentrates, product formulations and processing and packaging for ready to sell white-labelled products for third-party licensed producers; and

4) Manufacturing and distribution of our own proprietary Osoyoos Cannabis branded products for retail, allowing us to create greater margins upon sale and to build a lifestyle brand along the way.

Subsequent to the Phase One facility retrofit, which is expected to be completed in summer 2019, Osoyoos Cannabis will commence its Phase Two retrofit. This Phase will entail retrofitting the balance of the facility, adding more packaging equipment and doubling extraction capacity. Doing so will allow for the processing of up to 100,000 kilograms of flower annually which is expected to produce approximately 9,800 kilograms of output per year.

In addition to Osoyoos Cannabis’ application for a Standard Processing license, the Company is also in the process of negotiating a letter of intent relating to 100 acres of neighboring land with the intention of cultivating cannabis outdoors. The Okanagan Valley is the hottest and driest place in Canada, which is the ideal location to establish an outdoor grow. This low-cost cultivation method, combined with high-margin processing and product development expertise, will allow Osoyoos Cannabis to operate with some of the best economics in the industry.

Osoyoos Cannabis is excited to pursue these two fundamental strategies that capitalize on current industry themes: namely the production of cannabis concentrates and access to low cost input materials.

For a full description of the Company, readers are encouraged to review its Listing Statement dated February 20, 2019 which may be viewed at: www.SEDAR.com.

ON BEHALF OF THE BOARD

OSOYOOS CANNABIS INC.

“GERRY GOLDBERG”
Interim CEO and Executive Chairman

For further information contact:

Gerry Goldberg | ggoldberg@osoyooscannabis.com | (416) 460-3000

FORWARD-LOOKING INFORMATION

Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “may”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company’s current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the intention of the Company to become licensed in Canada to produce and sell cannabis extracts. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the parties being able to obtain the necessary corporate, regulatory and other third-party approvals; licensing and other risks associated with Cannabis Act (Canada) operations. The forward-looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.

This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.

Source: www.newsfilecorp.com

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less